Mizuho Initiates Coverage on Aflac (AFL) with Cautious Outlook Citing Stagnant Sales Growth

Aflac Incorporated (NYSE:AFL) is one of the most profitable value stocks to invest in right now. On December 16, Mizuho initiated coverage of Aflac with an Underperform rating and $104 price target. Mizuho maintains a cautious outlook on Aflac’s sales performance in its key Japanese and US markets. The firm believes that stagnant sales growth will effectively cap long-term earnings potential.

Earlier on December 3, Ameriflex and Aflac announced a partnership to enhance the delivery of consumer-directed health care/CDH solutions. Under this agreement, Dallas-based Ameriflex will serve as the official administrative partner for Aflac’s CDH services, specifically targeting the public sector market. This collaboration is designed to provide a seamless experience for public sector clients by combining Aflac’s supplemental insurance products with Ameriflex’s administrative expertise.

The partnership focuses on the administration of various spending accounts, including Flexible Spending Accounts/FSAs and Health Savings Accounts/HSAs. By using Ameriflex’s proven track record, Aflac aims to increase value, savings, and financial protection for its public sector customers and their employees. Leadership from both companies emphasized that the alliance aligns with their shared mission to provide reliable, hassle-free benefits solutions and innovative customer service.

Aflac Incorporated (NYSE:AFL), through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments: Aflac Japan and Aflac US.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.